Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
NETosis in the pathogenesis of acute lung injury following cutaneous chemical burns
Ranu Surolia, Fu Jun Li, Zheng Wang, Mahendra Kashyap, Ritesh Kumar Srivastava, Amie M. Traylor, Pooja Singh, Kevin G. Dsouza, Harrison Kim, Jean-Francois Pittet, Jaroslaw W. Zmijewski, Anupam Agarwal, Mohammad Athar, Aftab Ahmad, Veena B. Antony
Ranu Surolia, Fu Jun Li, Zheng Wang, Mahendra Kashyap, Ritesh Kumar Srivastava, Amie M. Traylor, Pooja Singh, Kevin G. Dsouza, Harrison Kim, Jean-Francois Pittet, Jaroslaw W. Zmijewski, Anupam Agarwal, Mohammad Athar, Aftab Ahmad, Veena B. Antony
View: Text | PDF | Corrigendum
Research Article Pulmonology

NETosis in the pathogenesis of acute lung injury following cutaneous chemical burns

  • Text
  • PDF
Abstract

Despite the high morbidity and mortality among patients with extensive cutaneous burns in the intensive care unit due to the development of acute respiratory distress syndrome, effective therapeutics remain to be determined. This is primarily because the mechanisms leading to acute lung injury (ALI) in these patients remain unknown. We test the hypothesis that cutaneous chemical burns promote lung injury due to systemic activation of neutrophils, in particular, toxicity mediated by the deployment of neutrophil extracellular traps (NETs). We also demonstrate the potential benefit of a peptidyl arginine deiminase 4 (PAD4) inhibitor to prevent NETosis and to preserve microvascular endothelial barrier function, thus reducing the severity of ALI in mice. Our data demonstrated that phenylarsine oxide (PAO) treatment of neutrophils caused increased intracellular Ca2+-associated PAD4 activity. A dermal chemical burn by lewisite or PAO resulted in PAD4 activation, NETosis, and ALI. NETs disrupted the barrier function of endothelial cells in human lung microvascular endothelial cell spheroids. Citrullinated histone 3 alone caused ALI in mice. Pharmacologic or genetic abrogation of PAD4 inhibited lung injury following cutaneous chemical burns. Cutaneous burns by lewisite and PAO caused ALI by PAD4-mediated NETosis. PAD4 inhibitors may have potential as countermeasures to suppress detrimental lung injury after chemical burns.

Authors

Ranu Surolia, Fu Jun Li, Zheng Wang, Mahendra Kashyap, Ritesh Kumar Srivastava, Amie M. Traylor, Pooja Singh, Kevin G. Dsouza, Harrison Kim, Jean-Francois Pittet, Jaroslaw W. Zmijewski, Anupam Agarwal, Mohammad Athar, Aftab Ahmad, Veena B. Antony

×

Figure 8

GSK484-attenuated PAO-mediated ALI in mice.

Options: View larger image (or click on image) Download as PowerPoint
GSK484-attenuated PAO-mediated ALI in mice.
WT mice were injected i.p. w...
WT mice were injected i.p. with GSK484 before the exposure to PAO on skin and sacrificed after 6 hours. (A) H&E staining, (B) lung injury score (n = 5/group), and (C) dsDNA in BAL fluid control, GSK484, PAO, and PAO and GSK484 groups (n = 5/group). Scale bar: 100 μm. (D) IHC staining of lung sections for Cit-H3 from control, GSK484, PAO, and PAO and GSK484 groups. Scale bar: 100 μm. Lower panel original magnification, ×2500. (E) Measurements of DAB intensity from IHC for Cit-H3. An average measurement from 5 mice was calculated from the average of 8 images. (F) Soluble vWF levels in serum (n = 5/group). (G) Western blot analysis for PAD4 and Cit-H3 expression in lung homogenates (n = 3). (H) Western blot densitometry for Cit-H3 and PAD4. The Cit-H3 and PAD4 densitometry was normalized with β-actin. (I) vWF levels in the serum (n = 5/group). (J) Fold changes in the protein leak in BAL fluid from control, PAO, PAD4–/–, PAD4–/– PAO, GSK484, and GSK484 and PAO groups (n = 5–6 mice/group). Statistics: (B and C) box-and-whiskers plots display median, and whiskers show maximum to minimum value. Each symbol represents individual mouse. **P < 0.01. Data were analyzed by using 1-way ANOVA followed by Tukey’s multiple comparisons test. In graphs (E and G–J), data are shown as the mean ± SEM. *P < 0.05,**P < 0.01.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts